Thomas Andersen Schmidt

Medicine & Life Sciences

1. Activities of Daily Living 16%
2. Adenosine Triphosphatases 22%
3. Aortic Valve 44%
4. Atrial Fibrillation 22%
5. Bacteria 15%
6. Cardiology 22%
7. Cardiovascular Diseases 17%
8. Constriction 21%
9. Coronary Artery Bypass 21%
10. Coronary Vessels 18%
11. Critical Care 19%
12. Critical Illness 20%
13. DNA Sequence Analysis 22%
14. Elderly 45%
15. Emergencies 20%
16. Factor VIIa 30%
17. Heart Valves 25%
18. Homeostasis 19%
19. Hospital Emergency Service 67%
20. Hospitalization 100%
21. Hydroxymethylglutaryl-CoA Reductase Inhibitors 21%
22. Hyperkalemia 55%
23. Insulin 15%
24. Intensive Care Units 17%
25. Internal Medicine 99%
26. Intraosseous Infusions 39%
27. Length of Stay 20%
28. Mortality 28%
29. Observational Studies 52%
30. Odds Ratio 18%
31. Operative Time 21%
32. Ouabain 19%
33. Placebos 15%
34. Potassium 43%
35. Pragmatic Clinical Trials 36%
36. Pulmonary Atelectasis 26%
37. Quality of Life 18%
38. Random Allocation 24%
39. Randomized Controlled Trials 55%
40. recombinant FVIIa 31%
41. Renin-Angiotensin System 23%
42. Ribosomal DNA 26%
43. Ribosomal RNA 28%
44. RNA Sequence Analysis 25%
45. Rodentia 18%
46. Safety 15%
47. sodium-translocating ATPase 24%
48. Starvation 24%
49. Sternotomy 41%
50. Thoracic Surgery 39%